AstraZeneca keeps low beta issuance going with fours and nines

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Corporate Bonds

AstraZeneca keeps low beta issuance going with fours and nines

Mike Turner
February 24, 2023 11:37 am
Molecule from AstraZeneca media gallery May21 575x375

UK pharma latest high rated company to hit the euro market this week

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Corporate BondsHigh grade and crossover bondsEuroBank of AmericaHSBCMizuhoSantanderHealth and Biotech
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article